VVOS
Vivos Therapeutics, Inc.
NASDAQ · USHealthcareMedical - Devices
$0.41-1.98%
Price as of Jul 20, 2026
VVOS profitability
Vivos Therapeutics, Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 59.5%
- EBITDA margin
- -120.3%
- EBIT margin
- -115.5%
- Net margin
- -128.4%
- Free cash flow margin
- -93.3%
Returns
- Return on equity
- 2207.2%
- Return on assets
- -100.3%
- Return on invested capital
- -203.0%
- Asset turnover
- 0.78x
Cash efficiency
- Cash from operations
- -$17.5M
- Cash per share
- $0.15
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.